CIK 0001357459 · Non-accelerated filer<br>Smaller reporting company
PALISADE BIO, INC.
Sign in to watch- Ticker
- PALI
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522007292
- Phone
- (858) 704-4900
- Business address
- 7750 EL CAMINO REAL, SUITE 5200, CARLSBAD, CA, 92009
- Former names
- PALISADE BIO, INC., Seneca Biopharma, Inc., Neuralstem, Inc.
- 4 Open-market buy Director bought 20,000 shares at $0.54 ($10,800)
- 4 Open-market buy CEO, CFO, Director bought 15,000 shares at $0.54 ($8,088)
- 4 Open-market sale Director sold 300 shares at $0.64 ($192)
- 4 Open-market buy CEO, CFO, Director bought 15,000 shares at $0.66 ($9,825)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CEO, CFO, Director gave up 1,792 shares (to pay taxes)
- 4 Shares withheld for taxes CEO, CFO, Director gave up 1,040 shares (to pay taxes)
- 4 Shares withheld for taxes CEO, CFO, Director gave up 389 shares (to pay taxes)
- 4 Shares withheld for taxes CEO, CFO, Director gave up 1,050 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Operating Officer gave up 270 shares (to pay taxes)
- 4 Shares withheld for taxes CEO, CFO, Director gave up 435 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
Page 5 of 18 · 343 filings